BCL9 Antikörper (AA 1009-1328)
-
- Target Alle BCL9 Antikörper anzeigen
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Bindungsspezifität
- AA 1009-1328
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Recognizes human Bcl-9 at ~149kD.
- Aufreinigung
- Protein G purified
- Sterilität
- Sterile filtered
- Immunogen
-
Recombinant human Bcl-9, aa1009-1328, O00512 (E. coli).
Type of Immunogen: Recombinant protein - Isotyp
- IgG2b
- Top Product
- Discover our top product BCL9 Primärantikörper
-
-
- Applikationshinweise
-
Approved: WB (0.5 μg/mL)
Usage: Suitable for use in Western blot: 0.5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 40-50 % glycerol, PBS.
- Konzentration
- Lot specific
- Buffer
- Lyophilized from 0.2 um sterile-filtered solution in PBS, 5 % trehalose
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Lyophilized powder may be stored at 4°C for short-term only. Reconstituted product is stable for 1 year at -20°C.
-
- Target
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
- Andere Bezeichnung
- BCL9 (BCL9 Produkte)
- Synonyme
- lgs antikoerper, xbcl9 antikoerper, legless antikoerper, MGC83888 antikoerper, BCL9 antikoerper, 2610202E01Rik antikoerper, 8030475K17Rik antikoerper, A330041G23Rik antikoerper, Gm130 antikoerper, LGS antikoerper, B-cell CLL/lymphoma 9 L homeolog antikoerper, B-cell CLL/lymphoma 9 antikoerper, B cell CLL/lymphoma 9 antikoerper, bcl9.L antikoerper, BCL9 antikoerper, Bcl9 antikoerper
- Hintergrund
-
Name/Gene ID: BCL9
Family: Cancer
Synonyms: BCL9, Bcl-9, B-cell CLL/lymphoma 9, B-cell CLL/lymphoma 9 protein, LGS, Protein legless homolog, B-cell lymphoma 9 protein - Gen-ID
- 607
- Pathways
- Stem Cell Maintenance
-